Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that are as distinct to cells as the ocean and desert are to animals. The ...

Cases of pancreatic cancer have increased significantly among younger individuals compared with those aged 35 years and older during the past 2-plus decades, according to results of a ...

CINCINNATI — The Pancreatic Cancer Action Network is getting ready for its annual "PanCan PurpleStride Walk" this week. The event aims to make a difference in finding a cure for pancreatic cancer.

A laboratory on Long Island has found a breakthrough in the fight against pancreatic cancer that can “intercept” its spread. Now Amy Pollaci, whose father Bill Reindl was diagnosed with stage ...

Until recently, the mainstay of systemic treatment of pancreatic cancer has been chemotherapy. 1,2 The first treatment to be approved for advanced pancreatic cancer was gemcitabine, which was tested ...

Namodenoson is an oral drug being investigated for its potential to treat advanced liver cancer, pancreatic cancer and metabolic dysfunction-associated steatohepatitis. The investigational agent works ...

The American Cancer Society estimates that about 67,440 Americans (34,950 men and 32,490 women) will be diagnosed with pancreatic cancer this year. Of those, about 51,980 people (27,050 men and ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high ...

Can Pancreatic Cancer Be Caught Early? “Detecting pancreatic cancer early helps increase chances of survival; however, it is challenging, and unfortunately, it’s not commonly detected at early ...

Pancreatic cancer has a low survival rate and is usually found too late — this new test may help change that Getty Researchers have developed an inexpensive blood test that they say can detect ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the most deadly forms of the disease. Tests showed up to 85% accuracy in ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study co-author Dr. Vinod Balachandran talks about the impact on future cancer care.